Human brown adipose tissue function: insights from current in vivo techniques

J Endocrinol. 2023 Aug 18;259(1):e230017. doi: 10.1530/JOE-23-0017. Print 2023 Sep 1.

Abstract

The identification of brown adipose tissue (BAT) as a thermogenic organ in human adults approximately 20 years ago raised the exciting possibility of activating this tissue as a new treatment for obesity and cardiometabolic disease. [18F]Fluoro-2-deoxyglucose (18F-FDG) combined positron emission tomography and computed tomography (PET/CT) scanning is the most commonly used imaging modality to detect and quantify human BAT activity in vivo. This technique exploits the substantial glucose uptake by BAT during thermogenesis as a marker for BAT metabolism. 18F-FDG PET has provided substantial insights into human BAT physiology, including its regulatory pathways and the effect of obesity and cardiometabolic disease on BAT function. The use of alternative PET tracers and the development of novel techniques such as magnetic resonance imaging, supraclavicular skin temperature measurements, contrast-enhanced ultrasound, near-infrared spectroscopy and microdialysis have all added complementary information to improve our understanding of human BAT. However, many questions surrounding BAT physiology remain unanswered, highlighting the need for further research and novel approaches to investigate this tissue. This review critically discusses current techniques to assess human BAT function in vivo, the insights gained from these modalities and their limitations. We also discuss other promising techniques in development that will help dissect the pathways regulating human thermogenesis and determine the therapeutic potential of BAT activation.

Keywords: brown adipose tissue; diabetes; infrared thermography; magnetic resonance imaging; microdialysis; obesity; positron emission tomography.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue, Brown* / diagnostic imaging
  • Adult
  • Cardiovascular Diseases*
  • Fluorodeoxyglucose F18
  • Humans
  • Obesity
  • Positron Emission Tomography Computed Tomography

Substances

  • Fluorodeoxyglucose F18